The normalization of mRNA technology is seen as a gateway to a trillion-dollar gene-editing industry using CRISPR. The hosts discuss the potential for customized treatments tailored to an individual's DNA, moving the pharmaceutical market toward selling to healthy people. They reference past efforts to develop vaccines for social issues like cocaine addiction and smoking.